Abstract

BackgroundBiological therapy, especially anti-tumor necrosis factor alpha, increases the risk of reactivation of latent tuberculosis (TB) infection in patients with rheumatoid arthritis (RA) (1). The influence of the underlying RA...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call